Investors Are Watching : WPX Energy, Inc. (NYSE:WPX), American International Group, Inc. (NYSE:AIG), Dendreon Corp. (NASDAQ:DNDN), Kennedy-Wilson Holdings, Inc. (NYSE:KW), Acceleron Pharma, Inc. (NASDAQ:XLRN)

Oklahoma-based oil and gas producer WPX Energy Inc. (NYSE:WPX) is going all-in on a trio of core oil and gas plays in North Dakota, Colorado and New Mexico, according to tulsaworld.com. The firm announced a new five-year strategy today that contains stake in the Williston, Piceance and San Juan basins. The strategy is in place to simplify WPX’s geographic focus and expand return margins, and … Continue reading Investors Are Watching : WPX Energy, Inc. (NYSE:WPX), American International Group, Inc. (NYSE:AIG), Dendreon Corp. (NASDAQ:DNDN), Kennedy-Wilson Holdings, Inc. (NYSE:KW), Acceleron Pharma, Inc. (NASDAQ:XLRN)

5 Stocks Under Wall Street’s Radar: Western Union (NYSE:WU), North American Palladium (NYSEMKT:PAL), Steelcase (NYSE:SCS), Dendreon Corp. (NASDAQ:DNDN), iKang Healthcare (NASDAQ:KANG)

The Western Union Company (NYSE:WU), a leader in global payment services, on 26 Aug 2014 announced that consumers in Austria, Belgium, Germany, the Netherlands and the United Kingdom now have the option to fund online and mobile Western UnionMoney Transfer® transactions using their bank accounts. The Western Union Company (NYSE:WU) belongs to Financial sector. Its net profit margin is 14.00% and weekly performance is -0.11%. … Continue reading 5 Stocks Under Wall Street’s Radar: Western Union (NYSE:WU), North American Palladium (NYSEMKT:PAL), Steelcase (NYSE:SCS), Dendreon Corp. (NASDAQ:DNDN), iKang Healthcare (NASDAQ:KANG)

Worth Watching Stocks: Dendreon Corp. (NASDAQ:DNDN), Puma Biotechnology (NYSE:PBYI), Itron (NASDAQ:ITRI), Beacon Roofing Supply, Inc. (NASDAQ:BECN), Encore Capital Group, Inc. (NASDAQ:ECPG)

On July 30,2014 Dendreon Corporation (Nasdaq: DNDN) announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the Company’s board of directors. Mr. Amick succeeds John H. Johnson, who previously announced his plans to step down as president and chief executive officer for personal reasons. Mr. Johnson will work with … Continue reading Worth Watching Stocks: Dendreon Corp. (NASDAQ:DNDN), Puma Biotechnology (NYSE:PBYI), Itron (NASDAQ:ITRI), Beacon Roofing Supply, Inc. (NASDAQ:BECN), Encore Capital Group, Inc. (NASDAQ:ECPG)

Worth Watching Stocks : Dendreon (NASDAQ:DNDN), Sigma Designs (NASDAQ:SIGM), G&K (NASDAQ:GK), Advanced Micro Devices, Inc. (NYSE:AMD), Quad/Graphics (NYSE:QUAD)

On July 30,2014 Dendreon Corporation (Nasdaq: DNDN) announced that its board of directors has appointed W. Thomas Amick as president and chief executive officer, effective immediately. Mr. Amick has also been appointed to the Company’s board of directors. Mr. Amick succeeds John H. Johnson, who previously announced his plans to step down as president and chief executive officer for personal reasons. Mr. Johnson will work with … Continue reading Worth Watching Stocks : Dendreon (NASDAQ:DNDN), Sigma Designs (NASDAQ:SIGM), G&K (NASDAQ:GK), Advanced Micro Devices, Inc. (NYSE:AMD), Quad/Graphics (NYSE:QUAD)

Healthcare Sector Most Active: Pfizer Inc. (NYSE:PFE), Novavax (NASDAQ:NVAX), Boston Scientific Corporation (NYSE:BSX), Dendreon Corporation (NASDAQ:DNDN)

Pfizer Inc. (NYSE:PFE) has begun testing an over-the-counter version of Lipitor, the blockbuster drug that has plumped up the pharmaceutical giant’s coffers for more than a decade. Pfizer Inc. (NYSE:PFE) stock performance was 2.22% in last session and finished the day at $32.69. Traded volume was 26,325,091 million shares in the last session and the average volume of the stock remained 26.27 million shares. The … Continue reading Healthcare Sector Most Active: Pfizer Inc. (NYSE:PFE), Novavax (NASDAQ:NVAX), Boston Scientific Corporation (NYSE:BSX), Dendreon Corporation (NASDAQ:DNDN)

Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)